RIZATRIPTAN AH rizatriptan (as benzoate) 10 mg orally disintegrating tablets blisters

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
26-11-2017

유효 성분:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

제공처:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

rizatriptan benzoate

약제 형태:

Tablet, orally disintegrating

구성:

Excipient Ingredients: acesulfame potassium; ethylcellulose; silicon dioxide; mannitol; crospovidone; hypromellose; sodium stearylfumarate; colloidal anhydrous silica; Flavour

관리 경로:

Sublingual

패키지 단위:

3, 2, 6, 1

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

for acute treatment of migraine attacks with or without aura.

제품 요약:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C7' on one side and 'C' on the other side, having a characteristic flavour.; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

승인 상태:

Licence status A

승인 날짜:

2015-03-20